Suppr超能文献

静脉注射和口服泼尼松龙的药代动力学

Pharmacokinetics of intravenous and oral prednisolone.

作者信息

Al-Habet S, Rogers H J

出版信息

Br J Clin Pharmacol. 1980 Nov;10(5):503-8. doi: 10.1111/j.1365-2125.1980.tb01796.x.

Abstract

1 Doses of 16, 32, 48 and 64 mg prednisolone were administered intravenously to normal volunteers who also received 100 prednisolone orally. Plasma prednisolone concentrations were estimated by quantitative thin layer chromatography. 2 The bioavailability fraction was 1.063 +/- 0.154 (s.d.) indicating complete availability of prednisolone following oral administration. 3 The mean T 1/2 over all doses were 4.11 +/- 0.97 (s.d.) h and there was no evidence of a dose-related change in its value. 4 The mean systemic clearance over all doses was 0.104 +/- 0.034 (s.d) 1 h-1 kg-1. There was no evidence of a dose-related change in clearance or in the apparent volume of distribution (overall mean 0.588 +/- 0.152 1 kg-1). 5 The area under the plasma concentration-time curve was linearly related to dose. 6 Plasma concentration-time curves normalised for dose were superimposable. 7 It was concluded that over the dose range investigated, non-linear pharmacokinetic behaviour had not been demonstrated in this group of normal volunteers.

摘要
  1. 给正常志愿者静脉注射16毫克、32毫克、48毫克和64毫克的泼尼松龙,这些志愿者还口服了100毫克泼尼松龙。通过定量薄层色谱法估算血浆泼尼松龙浓度。

  2. 生物利用度分数为1.063±0.154(标准差),表明口服后泼尼松龙完全可用。

  3. 所有剂量的平均半衰期为4.11±0.97(标准差)小时,且无证据表明其值存在剂量相关变化。

  4. 所有剂量的平均全身清除率为0.104±0.034(标准差)升·小时⁻¹·千克⁻¹。没有证据表明清除率或表观分布容积存在剂量相关变化(总体平均值为0.588±0.152升·千克⁻¹)。

  5. 血浆浓度-时间曲线下面积与剂量呈线性相关。

  6. 按剂量归一化的血浆浓度-时间曲线可叠加。

  7. 得出结论,在所研究的剂量范围内,该组正常志愿者未表现出非线性药代动力学行为。

相似文献

1
Pharmacokinetics of intravenous and oral prednisolone.静脉注射和口服泼尼松龙的药代动力学
Br J Clin Pharmacol. 1980 Nov;10(5):503-8. doi: 10.1111/j.1365-2125.1980.tb01796.x.
4
Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
Biopharm Drug Dispos. 1985 Oct-Dec;6(4):423-32. doi: 10.1002/bdd.2510060408.
8
Prednisolone bioavailability in the dog.泼尼松龙在犬体内的生物利用度。
J Pharm Sci. 1977 Dec;66(12):1751-4. doi: 10.1002/jps.2600661225.

引用本文的文献

1
Targeted Treatments for Myasthenia Gravis in Children and Adolescents.儿童和青少年重症肌无力的靶向治疗。
Paediatr Drugs. 2024 Nov;26(6):719-740. doi: 10.1007/s40272-024-00649-3. Epub 2024 Aug 28.
2
Supporting patients with hypercapnia.为高碳酸血症患者提供支持。
Clin Med (Lond). 2024 Jan;24(1):100007. doi: 10.1016/j.clinme.2023.100007. Epub 2024 Jan 18.
5
Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病
Am J Lifestyle Med. 2016 Jul 7;11(4):296-302. doi: 10.1177/1559827616656593. eCollection 2017 Jul-Aug.

本文引用的文献

4
Dose dependent pharmacokinetics of prednisolone.
Eur J Clin Pharmacol. 1977 Nov 14;12(3):213-9. doi: 10.1007/BF00609864.
5
Plasma protein binding of prednisolone in normal volunteers and arthritic patients.
Eur J Clin Pharmacol. 1979;16(6):399-404. doi: 10.1007/BF00568200.
7
Dose-dependent prednisolone kinetics.剂量依赖性泼尼松龙动力学。
Clin Pharmacol Ther. 1979 May;25(5 Pt 1):571-8. doi: 10.1002/cpt1979255part1571.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验